ARCHIVES

Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.”

This article is from The Cancer Letter archive.

Vol. 30 No. 41 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI CTEP Last Month

December 31, 2010

I-ELCAP Moves From Weill Cornell To Arizona State; PIs Move To Mount Sinai.

January 22, 2010

Congress Passes Unprecedented 15% Increase For NIH On Last Day Of Session

October 23, 1998

ASCO Annual Meeting: New Approaches For Treatment of Hematologic Malignancies

June 30, 2006

Washington Braces For Oncologists; It’s The Spring Meetings

May 4, 1990

Toxicity, Non-Cancer Deaths Increase With Combo Therapy

July 30, 2010